{
    "clinical_study": {
        "@rank": "40310", 
        "arm_group": [
            {
                "arm_group_label": "insulin pump", 
                "arm_group_type": "Experimental", 
                "description": "subjects will use an insulin pump for the duration of the pregnancy"
            }, 
            {
                "arm_group_label": "Multiple Daily Insulin injections", 
                "arm_group_type": "Active Comparator", 
                "description": "subjects will continue their usual insulin treatment with multiple daily injections of sc insulin"
            }
        ], 
        "brief_summary": {
            "textblock": "This study is investigating whether insulin treatment with the insulin pump or with multiple\n      daily injections (MDI) gives better outcomes for mother and baby in pregnant women with\n      pregestational diabetes. Participants will be randomized to use either the insulin pump or\n      MDI."
        }, 
        "brief_title": "Comparison of Insulin Pump and MDI for Pregestational Diabetes During Pregnancy", 
        "completion_date": {
            "#text": "January 2017", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Type 1 Diabetes", 
            "Type 2 Diabetes", 
            "Pregnancy"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus", 
                "Diabetes Mellitus, Type 1", 
                "Diabetes Mellitus, Type 2", 
                "Diabetes, Gestational"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  subjects are attending the Diabetes Pregnancy Clinic at participating hospitals\n\n          -  have had type 1 or type 2 diabetes for at least one year\n\n          -  are in the first trimester or are actively attempting pregnancy\n\n          -  have a singleton pregnancy\n\n          -  are receiving intensive insulin therapy\n\n          -  are judged by clinic staff to be capable of using an insulin pump\n\n          -  are age 19 or older\n\n          -  are willing to adhere to the study protocol including monitoring blood glucose levels\n\n          -  are willing to take folic acid before pregnancy and during the first trimester\n\n          -  are willing to discontinue any medication contraindicated in pregnancy prior to\n             conception\n\n          -  weigh less than 100 kg (220 lb) prior to becoming pregnant\n\n          -  use less than 100 units of insulin per day\n\n        Exclusion Criteria:\n\n          -  current or previous use of an insulin pump\n\n          -  use of fertility treatments\n\n          -  have a multiple pregnancy\n\n          -  have had children born with major birth defects\n\n          -  have experienced stillbirth or multiple early pregnancy losses\n\n          -  have significant diabetes complications or a serious medical issue"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "19 Years"
        }, 
        "enrollment": {
            "#text": "160", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 3, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02064023", 
            "org_study_id": "H12-02375"
        }, 
        "intervention": [
            {
                "arm_group_label": "insulin pump", 
                "description": "subjects in the experimental arm will administer insulin using a pump", 
                "intervention_name": "Animas", 
                "intervention_type": "Device", 
                "other_name": "insulin pump"
            }, 
            {
                "arm_group_label": "Multiple Daily Insulin injections", 
                "description": "Subjects will continue with usual insulin injections", 
                "intervention_name": "multiple daily insulin injection", 
                "intervention_type": "Other"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Insulin"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "insulin pump", 
            "CSII", 
            "multiple daily injections", 
            "MDI", 
            "type 1 diabetes", 
            "type 2 diabetes", 
            "pregnancy"
        ], 
        "lastchanged_date": "February 14, 2014", 
        "location": [
            {
                "contact": {
                    "email": "kreena@mail.ubc.ca", 
                    "last_name": "Reena Khurana, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Surrey", 
                        "country": "Canada", 
                        "state": "British Columbia", 
                        "zip": "V3T 0G9"
                    }, 
                    "name": "Jim Pattison Outpatient Care and Surgery Centre"
                }, 
                "investigator": {
                    "last_name": "Reena Khurana, MD", 
                    "role": "Sub-Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "david.thompson@vch.ca", 
                    "last_name": "David M Thompson, MD", 
                    "phone": "604-875-5996"
                }, 
                "facility": {
                    "address": {
                        "city": "Vancouver", 
                        "country": "Canada", 
                        "state": "British Columbia"
                    }, 
                    "name": "B.C. Women's Hospital"
                }, 
                "investigator": {
                    "last_name": "David M Thompson, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "Canada"
        }, 
        "number_of_arms": "2", 
        "official_title": "Comparison of Continuous Subcutaneous Insulin Infusion (CSII) With Multiple Daily Injections (MDI) for the Treatment of Pregestational Diabetes During Pregnancy", 
        "other_outcome": {
            "description": "Severe hypoglycemia is defined as capillary glucose < 3.3 mmol/L requiring the assistance of another person for treatment.", 
            "measure": "Number of episodes of severe hypoglycemia", 
            "safety_issue": "No", 
            "time_frame": "up to 42 weeks"
        }, 
        "overall_contact": {
            "email": "david.thompson@vch.ca", 
            "last_name": "David M Thompson, MD", 
            "phone": "604-875-5996"
        }, 
        "overall_contact_backup": {
            "email": "sharon.thompson@cw.bc.ca", 
            "last_name": "Sharon E Thompson, RN", 
            "phone": "604-875-2339"
        }, 
        "overall_official": {
            "affiliation": "University of British Columbia", 
            "last_name": "David M Thompson, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Canada: Health Canada", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Composite obstetrical/perinatal endpoint consisting of one or more of pre-eclampsia, primary caesarian section, pre-term delivery, spontaneous abortion, termination for congenital anomaly or chromosomal abnormality, perinatal mortality, large-for-gestational age, shoulder dystocia, birth injury, major congenital anomaly, neonatal hypoglycemia, jaundice requiring phototherapy, or admission to neonatal intensive care nursery.", 
            "measure": "Composite obstetrical/perinatal endpoint consisting of specific elements (see description)", 
            "safety_issue": "No", 
            "time_frame": "Up to 42 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02064023"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "HbA1c will be measured at least every three months to provide information about overall glycemic control", 
            "measure": "Mean maternal HbA1c during pregnancy", 
            "safety_issue": "No", 
            "time_frame": "up to 42 weeks"
        }, 
        "source": "University of British Columbia", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of British Columbia", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}